FDAFDA · Food and drugs·Recall number D-0262-2024
Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.
Published January 31, 2024 · Recall initiated: January 10, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Sterility Assurance: Aseptic process simulation failure.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- FOSAPREPITANT
- Manufacturer
- BE PHARMACEUTICALS AG
- Distributor
- Nationwide in the USA
- UPC
- 0371839104017
- Lot
- lot #13D012AA, Exp: 08/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Switzerland
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.